Literature DB >> 2589595

Significance of tumor spread in adenocarcinoma of the ampulla of Vater.

R Delcore1, C S Connor, J H Thomas, S R Friesen, A S Hermreck.   

Abstract

Twenty-eight patients with ampullary carcinoma were treated between 1965 and 1988: 22 underwent pancreaticoduodenectomy with 1 operative death (5 percent), 1 had local excision, 3 had bypass, and 2 were not explored. Of the 21 patients who survived pancreaticoduodenectomy, 4 had tumor confined to the ampulla, 7 had tumor extending into the duodenum, and 10 had tumor invasion beyond the duodenum. Nine of these patients had positive lymph nodes and 12 had negative lymph nodes. The patient who had local excision was disease-free at last follow-up 104 months postoperatively. Each of the three bypassed patients died of tumor progression within 15 months. The estimated 5-year survival rate for resected patients was 60 percent and was independently related to lymph node metastases (p = 0.031) and to tumor size (p = 0.039). This experience suggests that long-term survival is possible in patients with lymph node metastases or invasive tumors extending beyond the duodenal wall and that curative pancreaticoduodenectomy can be performed with a low operative mortality; therefore, aggressive surgical resection is recommended for all patients with ampullary carcinoma.

Entities:  

Mesh:

Year:  1989        PMID: 2589595     DOI: 10.1016/0002-9610(89)90201-8

Source DB:  PubMed          Journal:  Am J Surg        ISSN: 0002-9610            Impact factor:   2.565


  12 in total

1.  Carcinoma of the ampulla of Vater: prognostic factors after curative surgery: a series of 45 cases.

Authors:  A Dorandeu; J L Raoul; F Siriser; N Leclercq-Rioux; M Gosselin; E D Martin; M P Ramée; B Launois
Journal:  Gut       Date:  1997-03       Impact factor: 23.059

2.  Tumor budding as a strong prognostic indicator in invasive ampullary adenocarcinomas.

Authors:  Nobuyuki Ohike; Ipek Coban; Grace E Kim; Olca Basturk; Takuma Tajiri; Alyssa Krasinskas; Sudeshna Bandyopadhyay; Toshio Morohoshi; Yuki Shimada; David A Kooby; Charles A Staley; Michael Goodman; N Volkan Adsay; Nazmi Volkan Adsay
Journal:  Am J Surg Pathol       Date:  2010-10       Impact factor: 6.394

3.  Clinical significance of lymph node micrometastasis in ampullary carcinoma.

Authors:  Eiko Sakata; Yoshio Shirai; Naoyuki Yokoyama; Toshifumi Wakai; Jun Sakata; Katsuyoshi Hatakeyama
Journal:  World J Surg       Date:  2006-06       Impact factor: 3.352

4.  Photodynamic therapy for malignant tumours of the ampulla of Vater.

Authors:  A M Abulafi; J T Allardice; N S Williams; N van Someren; C P Swain; C Ainley
Journal:  Gut       Date:  1995-06       Impact factor: 23.059

5.  Periampullary adenocarcinoma: analysis of 5-year survivors.

Authors:  C J Yeo; T A Sohn; J L Cameron; R H Hruban; K D Lillemoe; H A Pitt
Journal:  Ann Surg       Date:  1998-06       Impact factor: 12.969

6.  Review of standards for reporting results of treatment of exocrine pancreatic cancer.

Authors:  A Andrén-Sandberg; C Cedercrantz
Journal:  Int J Pancreatol       Date:  1993-12

7.  Factors predictive of survival in ampullary carcinoma.

Authors:  J R Howe; D S Klimstra; R D Moccia; K C Conlon; M F Brennan
Journal:  Ann Surg       Date:  1998-07       Impact factor: 12.969

8.  Evaluation of adjuvant chemoradiation therapy for ampullary adenocarcinoma: the Johns Hopkins Hospital-Mayo Clinic collaborative study.

Authors:  Amol K Narang; Robert C Miller; Charles C Hsu; Sumita Bhatia; Timothy M Pawlik; Dan Laheru; Ralph H Hruban; Jessica Zhou; Jordan M Winter; Michael G Haddock; John H Donohue; Richard D Schulick; Christopher L Wolfgang; John L Cameron; Joseph M Herman
Journal:  Radiat Oncol       Date:  2011-09-28       Impact factor: 3.481

9.  Our local experience with the surgical treatment of ampullary cancer.

Authors:  Dimitrios Botsios; Emmanouil Zacharakis; Ioannis Lambrou; Kostas Tsalis; Emmanouil Christoforidis; Stavros Kalfadis; Evangelos Zacharakis; Dimitrios Betsis; Ioannis Dadoukis
Journal:  Int Semin Surg Oncol       Date:  2005-08-30

10.  Adenocarcinoma of the ampulla of Vater: T-stage, chromosome 17p allelic loss, and extended pancreaticoduodenectomy are relevant prognostic factors.

Authors:  Calogero Iacono; Giuseppe Verlato; Giuseppe Zamboni; Aldo Scarpa; Ettore Montresor; Paola Capelli; Luca Bortolasi; Giovanni Serio
Journal:  J Gastrointest Surg       Date:  2007-05       Impact factor: 3.267

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.